.jpg)
Fortis Hospitals are ultra-modern state-of-the-art tertiary care centres with world class doctors and cutting edge technology. In keeping with world standards and best practices in clinical medicine, Fortis takes great pride in measuring its Clinical Outcomes and sharing them in the public domain. As part of our core value of Patient Centricity, patients can now visualise and assess for themselves our clinical outcomes for various surgeries and procedures.
Fortis Hospitals are world class institutes rendering yeomen healthcare services to Indian as well as international patients. Fortis has adopted the world renowned ICHOM methodology for monitoring Clinical Outcomes to supplement our core value of Patient Centricity. Fortis firmly believes in being transparent in sharing our care quality indices with patients, and this a firm step in that direction.
Towards our passion to achieve Clinical Excellence, FHM has successfully monitored; evaluated and published clinical outcomes for both CABG & PTCA. We shall be publishing more specialties in near future. As it is said: ‘If you can’t measure it, you can’t improve it’, hence we strengthen our commitment to continuous improvement & our core value of Patient Centricity. Published FHM data is comparable to the international standards & benchmarks in the Clinical Outcomes and practice evidence-based patient care & transparency and we shall always do what is right in all times to come.
As we continue to drive more transparency and accountability in healthcare, it has become important to assess the quality, safety, and efficacy of medical interventions provided. Measuring and publishing clinical outcomes is therefore an imperative step towards patient empowerment. Being the first in India to adopt indicators set by International Consortium for Health Outcomes Measurement (ICHOM), we strongly believe in continuously measuring, analysing and improving our clinical outcomes, providing our prospective patients with an opportunity to make informed choices.
Fortis Healthcare Limited, one of the largest integrated, healthcare service provider in the country is the first hospital chain to implement and monitor clinical outcomes in India. This initiative further strengthens our commitment to PATIENT CENTRICITY by striving towards continuous clinical excellence through improvement and enhancement of our clinical care services. Further, introduction of Patient Reported Outcomes Measurement [PROM] lends the voice of patient to the entire process and helps enhance patient engagement and experience. Constant evaluation of our clinical outcomes against best available global standards motivates our medical work force to continuously improve all aspects of our practice.
Fortis clinical outcomes are based on measurement of disease course and progression, quality of clinical care being provided, success of the procedures/interventions carried out, and actual benefit perceived by the patient.
Details of individual procedure outcomes as measured using internationally accepted parameters and criteria, and further validated by our clinical experts, are published here and showcase our commitment to transparency in healthcare. Fortis is the FIRST to embark on the journey of publishing clinical outcomes data in the public realm.
Kick off with
Clinical Outcomes
Monitoring for
3 procedures – CABG,
PTCA, KTP
Fortis joins the
ICHOM Working Group
on
Coronary Artery Disease (CAD)
Fortis joins the
ICHOM Working Group
on
Coronary Artery Disease (CAD)
Partnership with Vital Health
(ICHOM certified
software supplier)
Implementation of
ICHOM CAD standard set
Implementation of
ICHOM CAD standard set
1st In India to publish
clinical outcomes
data
on website
CAD PROM
implemented
CAD PROM
implemented
About the procedure:
Coronary Artery Bypass Graft (CABG) is a surgical procedure which creates alternate routes for blood supply to heart, bypassing the diseased/blocked arteries. A blood vessel (called a ‘graft’) taken from another area of patient’s body is placed around the diseased/blocked area to restore blood flow, to relieve symptoms of coronary artery disease (like angina), enable the patient to resume a normal lifestyle and lower the risk of a heart attack.
Clinical Outcomes for CABG :
CABG outcome indicators provide measures of overall success of the surgery and patient’s post-procedure clinical condition. These parameters are globally accepted evidence-based scientific criteria to indicate quality of procedure and patient’s health status. Fortis hospitals measure the following outcomes parameters for CABG, and our performance consistently matches the global benchmarks set by best-in-class hospitals.
Outcome Parameters:
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 85.03% | 74.20%* |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 1.77% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.28% | 0.96%** |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.17% | 0.80%* |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 1.55% | 3.50%* |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.78% | 0.20%* |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 2.52% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 1.66% | -- |
This is an urgent life-saving procedure where an inflatable balloon is placed in the aorta to help the heart pump blood to the vital organs and body partsA heart attack occurring during or immediately after CABG. It is a predictor for short and long term disability and deathA Brain stroke occurring after CABG due to reduced blood flow to a brain partRedo surgery which may be needed to explore for any abnormal or unusual bleeding after CABGInfection involving tissue/muscle/bone involved in the surgical wound; this may require aggressive treatment including further surgeryThis is a predictor for risk of death after a cardiac operation. It is a globally accepted scoring system based on multiple factors like patient’s age, gender, clinical conditions and type of surgeryNumber of deaths reported in the observed patient group across different risk categories, expressed in percentageReferences
About the procedure:
Percutaneous transluminal coronary angioplasty (PTCA) , also known as coronary angioplasty, is a non-surgical technique for treating narrowed/blocked arteries which supply blood to the heart muscle. PTCA involves inserting a tiny balloon or stent across the narrowed part to widen the affected artery and restore blood flow to the heart muscle without requiring an open-heart surgery.
Clinical Outcomes for PTCA :
PTCA outcome indicators provide measures of overall success of the surgery and patient’s post-procedure clinical condition. These parameters are globally accepted evidence-based scientific criteria to indicate quality of procedure and patient’s health status. Fortis hospitals measure the following outcomes parameters for PTCA, and our performance consistently matches the global benchmarks set by best-in-class hospitals.
Outcome Parameters:
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.00% | 1.2% |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.11% | 1.1%* |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.03% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.00% | 0.284%** |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.08% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.22% | 4.0%* |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.03% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 0.19% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2017 | 1.40% | 1.7%* |
Local injury to the blood vessel puncture site [usually groin or wrist] may occur. Usually these require only pressure being applied by mechanical compression, but sometimes additional surgical or non-surgical measures may be requiredSudden narrowing of the blood vessel which requires urgent repeat/additional procedure to restore the blood supplyA Brain stroke occurring after PTCA due to reduced blood flow to a brain partAcute renal (kidney) failure is a rare but known complication resulting from acute kidney injury, more so in pre-existing renal failure patients, and may require dialysisIn a few cases, acute bleeding may occur after PTCA from the puncture site and evidence shows 4% of such incidences may require blood transfusion Vascular complications which may include occlusions at insertion site, peripheral embolization, tear and injury to blood vessels, bulging of the arterial wall and/or AV fistulas, may occur at a later period after procedure, even after dischargeA heart attack occurring immediately or within 30 days after PTCA. It is a predictor for long term disability and deathThough rare, both sudden cardiac death and death at a later stage my occur depending on a number of factors including Patient history of heart attack, multi-vessel disease, advanced age, complex lesions, Location of the blockage in the coronary artery, other conditionsReferences
About the procedure:
Kidney transplantation means replacement of the failed kidney with a healthy kidney from another person, called a donor, living or deceased. Kidney transplant provides significant quality-of-life benefits and survival in patients with end-stage kidney disease/Kidney failure.
Clinical Outcomes for Kidney Transplant :
Graft (transplanted kidney) survival is defined as survival of the transplanted kidney in a live recipient without requiring dialysis. Acute rejection within the first-year post-transplantation is a negative predictor of long-term renal allograft survival.
Outcome Parameters:
| Period | Outcome | Benchmarks |
|---|---|---|
| (Apr’ 2015 - Mar’ 2016) | 96.25% | 90-95%* 90-95%** 97%*** |
References
About the procedure:
Radiation is one of the most common treatments for cancer. It uses carefully measured and controlled high-energy particles or waves, such as x-rays, gamma rays, electron beams or protons aimed to destroy cancer cells in body. This therapy can also be combined with other treatment options like chemotherapy and surgery. The goal is to use this as primary curative treatment for cancer or adjuvant therapy or to prevent recurrence of tumour and improve a person’s quality of life. Sometimes in advanced or late-stage of a cancer, it is not possible to destroy all of the tumour cells, then doctors may use palliative radiation therapy to shrink tumours and relieve/reduce pain, pressure and other symptoms.
Clinical Outcomes for Radiation Oncology :
Every person reacts differently to treatment. Acute radiation toxicities are side effects that may occur during treatment or in the immediate post-treatment period, depending on the type of cancer, location, dose and length of radiation and patient’s general health. Onset may be 2–3 weeks after the commencement of a regimen of radiation therapy. Typically, severity and timing are tied to the total biologic dose and the turnover rate of the tissue in question, respectively.
Outcome Parameters:
| Period | Outcome | Benchmarks |
|---|---|---|
| 2016 | 77% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2016 | 23% | -- |
| Period | Outcome | Benchmarks |
|---|---|---|
| 2016 | 6.4% | 5 – 15% |
Radiation therapy may be given to relieve pain and other symptoms only in cancer patients when complete cure is not possible, in most cases patients with short term life expectancyDepending upon various factors systemic toxicity may affect different body systems involving Skin, Nervous system, lungs, Heart, Fertility etc.References
Radiation Therapy Oncology Group (RTOG) common toxicity criteria (CTC) v.2.0 Toxicity severity grading:-
